Penobscot Investment Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,200
Closed -$257K 187
2016
Q4
$257K Hold
3,200
0.09% 158
2016
Q3
$255K Hold
3,200
0.09% 157
2016
Q2
$250K Buy
+3,200
New +$228K 0.09% 158
2015
Q4
Sell
-3,200
Closed -$202K 193
2015
Q3
$202K Hold
3,200
0.07% 186
2015
Q2
$234K Sell
3,200
-1,000
-24% -$72.2K 0.07% 184
2015
Q1
$275K Buy
4,200
+200
+5% +$13.3K 0.09% 170
2014
Q4
$260K Hold
4,000
0.08% 170
2014
Q3
$241K Hold
4,000
0.08% 164
2014
Q2
$277K Hold
4,000
0.09% 150
2014
Q1
$262K Hold
4,000
0.09% 151
2013
Q4
$248K Hold
4,000
0.09% 154
2013
Q3
$215K Buy
+4,000
New +$206K 0.08% 153

Other funds holding STJ

Penobscot Investment Management's STJ Position: Q1 2017 in Review

Penobscot Investment Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,200 shares — an estimated $257K sold.

Penobscot Investment Management first reported a position in STJ in Q3 2013 and held it in 12 quarters. The position peaked at $277K in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Penobscot Investment Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Penobscot Investment Management sold 3,200 St Jude Medical shares in Q1 2017, an estimated $257K.
  • Penobscot Investment Management first reported a position in St Jude Medical in Q3 2013 and held it in 12 quarters.
  • Penobscot Investment Management's St Jude Medical position peaked at $277K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Penobscot Investment Management's 13F filing for Q1 2017, filed 25 Apr 2017.